UCLA Launches Phase II Pediatric Clinical Trial for the Treatment of ADHD with NeuroSigma's eTNS System

The U.S. National Institute of Mental Health (NIMH) has provided grant funding to support this double-blind controlled trial of eTNS in children with ADHD, ages 8 to 12. NeuroSigma will be providing eTNS systems for the trial. Children will use the eTNS ...



from Meta Search Alerts http://ift.tt/1HKH8Kc

via IFTTT